Can Allergy Shots Make Your Allergies Worse? Your Personal Risk Profile
Whether allergy shots make YOUR allergies worse during build-up depends on specific individual risk factors. The five key predictors: number of allergen sensitivities (polysensitization), baseline symptom severity, season of SCIT initiation, dose escalation speed, and concurrent medication use. Patients with high baseline disease burden starting in peak season without antihistamines face the highest risk. Knowing your profile before starting lets you design a protocol that minimizes worsening.
7 peer-reviewed sources
Whether allergy shots worsen your allergies depends on your individual risk profile. Polysensitized patients, those with severe baseline symptoms, and those starting during peak season have the highest worsening risk. Most risk factors can be modified with planning.
Key facts
A 2026 observational cohort of 2,897 patients on at-home sublingual immunotherapy reported clinically meaningful improvement rising from 28% at 12 months to 45% at 24 months, showing how benefit accrues with time on treatment rather than arriving early.
Your Personal Worsening Risk: What the Evidence Says About Individual Factors
The question 'can allergy shots make YOUR allergies worse' adds a word — 'your' — that transforms it from a general immunology question into a personal risk assessment. Not every patient experiences paradoxical worsening equally. The degree, duration, and clinical impact of build-up phase worsening varies significantly across individuals based on measurable, identifiable factors.
Understanding your personal risk profile before starting SCIT is valuable for two reasons: it sets realistic expectations (patients who are warned about potential worsening are less likely to quit), and it allows for protocol customization (allergists can adjust escalation speed, timing, and pre-medication based on predicted risk).
Five factors have the clearest evidence for predicting individual worsening risk: the number of allergens you're sensitized to (polysensitization), your baseline symptom severity before treatment, when you start SCIT relative to your peak allergen season, how quickly your dose is escalated, and whether you use concurrent antihistamines and nasal corticosteroids during build-up.
The more of your specific allergen sensitivities you know about before starting, the better your allergist can predict and manage your worsening risk — at-home allergy testing from Curex provides a comprehensive IgE panel covering 40+ allergens, giving both you and your allergist the full picture needed to design a personalized build-up protocol.
Importantly, having high worsening risk does NOT mean SCIT is wrong for you — it means the protocol should be customized to manage that risk effectively. Reassuringly, serious whole-body reactions stay uncommon even outside the clinic: a large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) recorded a systemic reaction rate of just 0.16% per patient across 23,614 patients giving 2,021,600 injections, with no fatalities — lower than the 3%–14% typically seen with office-based shots.
Individual worsening risk during SCIT build-up is predictable and modifiable. Discuss your specific risk factors with your allergist before starting so escalation timing, speed, and pre-medication can be tailored to your profile.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex at-home allergy shots are clinician-supervised; confirm your current program quote before enrolling.
Join the waitlistCurex allergy shot serum is compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
Reducing Worsening Risk: SCIT Protocol Options vs Alternatives
For patients whose risk profile suggests challenging build-up tolerability, understanding protocol options and alternatives helps with informed decision-making.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home SCIT, Weekly Escalation (Curex)Best | Gold standard; 60-90% achieve significant improvement with 3-5 years | 3-6 month build-up + 3-5 year maintenance | $3,000-10,000 insured | At-home self-administration with Curex; weekly during build-up, monthly at maintenance; the first injection from each new vial or concentration supervised live in the Virtual Shot Room | Lower systemic reaction rate than rush; 0.1-0.2% per visit |
Rush Immunotherapy | Same long-term efficacy; faster arrival at maintenance | 1-3 days build-up + 3-5 year maintenance | $3,000-10,000 insured | Very fast build-up; fewer initial visits | Higher short-term systemic reaction risk; not appropriate for all patients |
Symptom Control Only (Antihistamines/Steroids) | No disease modification; symptoms return when stopped | Ongoing indefinitely | $500-2,000 | Daily medications; no clinic visits | Generally safe; no worsening phase |
Sublingual Drops (SLIT) | Evidence-supported; may have gentler build-up for polysensitized patients | 3-5 years | $2,340 avg 5-yr | At-home daily drops; no needles; no clinic visits | Lower systemic reaction rates; primarily local oral mucosal effects |
- Efficacy
- Gold standard; 60-90% achieve significant improvement with 3-5 years
- Duration
- 3-6 month build-up + 3-5 year maintenance
- Cost (5yr)
- $3,000-10,000 insured
- Convenience
- At-home self-administration with Curex; weekly during build-up, monthly at maintenance; the first injection from each new vial or concentration supervised live in the Virtual Shot Room
- Safety
- Lower systemic reaction rate than rush; 0.1-0.2% per visit
- Efficacy
- Same long-term efficacy; faster arrival at maintenance
- Duration
- 1-3 days build-up + 3-5 year maintenance
- Cost (5yr)
- $3,000-10,000 insured
- Convenience
- Very fast build-up; fewer initial visits
- Safety
- Higher short-term systemic reaction risk; not appropriate for all patients
- Efficacy
- No disease modification; symptoms return when stopped
- Duration
- Ongoing indefinitely
- Cost (5yr)
- $500-2,000
- Convenience
- Daily medications; no clinic visits
- Safety
- Generally safe; no worsening phase
- Efficacy
- Evidence-supported; may have gentler build-up for polysensitized patients
- Duration
- 3-5 years
- Cost (5yr)
- $2,340 avg 5-yr
- Convenience
- At-home daily drops; no needles; no clinic visits
- Safety
- Lower systemic reaction rates; primarily local oral mucosal effects
For patients with multiple worsening risk factors who want immunotherapy without weekly clinic trips, Curex's at-home allergy shot kit (SCIT) offers pricing confirmed in a current program quote — the same disease-modifying shots, delivered from home. Your allergist tailors the gradual week-by-week escalation to your risk profile, you give yourself one weekly shot from a personalized serum sterile-compounded to USP <797>, and the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff once a prescribed epinephrine auto-injector is confirmed on hand. For eligible patients that means a customized, well-supported build-up at home rather than repeated clinic injections.
Join the waitlistThe Five Individual Risk Factors for Build-Up Phase Worsening
Each of the following risk factors has documented influence on the severity of paradoxical worsening during SCIT build-up. Some are fixed (your current number of sensitivities); others are modifiable through protocol design (escalation speed, timing, pre-medication). A complete risk assessment before starting SCIT allows your allergist to address as many modifiable factors as possible. Understanding which factors apply to you gives you specific questions to bring to your first allergist conversation — or your next one if you've already started and are experiencing worsening.
Patients reactive to 5 or more allergen categories (grass pollen, tree pollen, dust mites, cat dander, dog dander, mold spores, weed pollen) may experience more pronounced worsening during build-up because each injection stimulates IgE responses across a broader range of immune specificities. Broader Th2 stimulation produces more widespread mast cell activation. Polysensitized patients should discuss whether all identified allergens need to be in the initial extract formulation or whether a phased approach is appropriate.
Ensure comprehensive allergen testing before starting SCIT so the full sensitization profile is known. Discuss with your allergist whether initial extract complexity should be staged.
Patients with high baseline Total Nasal Symptom Score (TNSS above 8/12) or significant asthma burden have more room for perceptible worsening — their allergic inflammation is already elevated, and any amplification is more noticeable. Patients with mild baseline symptoms may experience worsening that remains sub-threshold for clinical concern. A formal symptom score measurement before starting SCIT provides a documented baseline for comparison during build-up.
Document your symptom scores before starting SCIT using a validated tool (TNSS, RQLQ). Optimize asthma and rhinitis control before initiating SCIT if possible. Use this baseline for objective comparison during build-up.
Starting SCIT during your primary allergen season — spring for tree and grass pollen, fall for ragweed, year-round for dust mites — compounds injection-mediated allergen stimulation with high ambient allergen exposure. The immune system is dealing with both sources simultaneously, amplifying the Th2 response beyond what either source would produce alone. Starting during an off-season (winter for seasonal pollen-sensitive patients) allows build-up to progress with less environmental background allergen load.
Discuss optimal timing with your allergist. For seasonal pollen-sensitive patients, initiating SCIT in fall or winter allows build-up to progress before the following spring season. Not always possible, but significantly beneficial when feasible.
Rush immunotherapy protocols (reaching maintenance dose in 1–3 days through multiple same-day injections) and cluster protocols (3–4 injections per visit over several weeks) produce higher systemic reaction rates and potentially more intense transient worsening than conventional weekly escalation (Tversky, 2022). The rapid allergen exposure surge produces stronger acute Th2 stimulation. For patients with multiple worsening risk factors, conventional escalation may be preferable despite requiring more clinic visits.
Discuss escalation protocol options with your allergist. If you have other high-risk factors, conventional weekly escalation may be preferred over rush. Rush protocols have benefits (faster arrival at maintenance) but should be balanced against individual risk.
This is a modifiable factor that REDUCES worsening. Patients who take daily non-sedating antihistamines (cetirizine, loratadine) during build-up report measurably less perceived symptom worsening. Nasal corticosteroid sprays provide additional mucosal protection. These medications manage the Th2-driven symptoms without interfering with the immunological re-education process. Patients who start SCIT without concurrent pharmacotherapy may experience more pronounced worsening than those with adequate symptom management support.
Before starting SCIT, ensure you have a concurrent allergy medication plan. Daily non-sedating antihistamines and nasal corticosteroids are the most effective combination. Discuss timing and dosing with your allergist.
Frequently asked questions
Can allergy shots make your allergies worse?
Yes, temporarily — whether this happens to you specifically depends on your individual risk profile. Paradoxical worsening during SCIT build-up is more likely in patients with: more allergen sensitivities (polysensitization to 5+ allergens), high baseline symptom severity, peak-season start, rapid escalation protocols, and inadequate concurrent medication use. Patients who manage these risk factors through protocol customization — off-season start, slower escalation, daily antihistamines during build-up — may experience less pronounced worsening. The mechanism is well-established: before Treg-mediated tolerance develops, injections stimulate the Th2 immune pathway (Akdis & Akdis, JACI, 2015). Long-term, 60–90% achieve significant improvement.
Who is most likely to have allergies worsen with allergy shots?
Patients most likely to experience pronounced paradoxical worsening during SCIT build-up are those with multiple concurrent risk factors: polysensitization to 5 or more allergen categories (grass, trees, dust mites, cats, dogs, mold), high baseline symptom severity (TNSS above 8/12 before treatment), starting SCIT during their primary allergen season, undergoing rush or cluster immunotherapy protocols, and using no concurrent antihistamines or nasal corticosteroids during build-up. A patient who has all five risk factors — severely symptomatic, polysensitized, starting in peak season, with rush protocol and no pre-medication — faces much higher worsening risk than a patient with controlled symptoms starting in off-season with conventional escalation and daily antihistamines.
Does starting allergy shots in winter reduce worsening?
Yes — starting SCIT during an allergen-free or low-allergen season (typically winter for patients with spring pollen sensitivities) is one of the most effective strategies for reducing build-up phase worsening. When you start in winter, your build-up progresses for 3–6 months before environmental allergen exposure ramps up in spring. By the time allergen season arrives, you may already be approaching or at maintenance dose, which is much better tolerated. This timing strategy has been supported in clinical practice for decades — some allergists refer to starting SCIT pre-seasonally or off-seasonally as a standard protocol optimization for patients at high worsening risk. Discuss with your allergist whether the timing of your start date can be optimized.
Does age affect how much allergy shots worsen symptoms?
Some clinical observations suggest that pediatric patients may tolerate SCIT build-up with less pronounced worsening than adults, possibly because children's immune systems are more plastic and more readily redirected toward tolerance. Children's immune systems have had less time to entrench Th2 patterns, and the regulatory mechanisms may be more responsive to immunotherapy-driven re-education. Adults, particularly those with long-standing established allergies, may experience more pronounced initial worsening because their Th2 patterns are more deeply established. This is one reason SCIT is frequently recommended in childhood — earlier treatment may offer smoother build-up and greater long-term disease modification. However, adult SCIT remains highly effective and should not be discouraged based on age considerations alone.
What can I do to prevent worsening when starting allergy shots?
Several strategies can reduce worsening risk before and during SCIT. Before starting: complete comprehensive allergy testing to know your full sensitization profile, then time your start for the off-season if your sensitivity is primarily seasonal, optimize existing allergy medication control, and discuss conventional vs rush escalation protocols with your allergist based on your risk factors. During build-up: take daily non-sedating antihistamines (cetirizine 10mg or loratadine 10mg), use nasal corticosteroids consistently, avoid starting during a peak allergy period if possible, and communicate any symptom changes to your allergist promptly. If worsening becomes pronounced, ask your allergist about slowing the escalation pace — accepting a longer build-up period in exchange for better tolerability is a valid trade-off for high-risk patients.
Is it normal for allergy shots to make you sneeze more?
Increased sneezing during SCIT build-up — particularly if it occurs within 30–60 minutes of injection — can be a sign of nasal mast cell activation from the allergen dose. This is part of the paradoxical worsening phenomenon: the same immune stimulation being delivered for therapeutic purposes also transiently amplifies allergic nasal symptoms. Sneezing that occurs during the 30-minute observation period should be reported to your care team as it may indicate a mild systemic reaction component requiring evaluation. Increased sneezing at home in the days following injections, if not severe, is a recognized build-up phase symptom that typically decreases as maintenance dose is reached. Daily antihistamines during build-up can measurably reduce injection-day and post-injection sneezing.
How do I know if worsening is temporary or treatment failure?
Distinguishing temporary build-up worsening from genuine treatment failure requires time-based assessment. Temporary build-up worsening: occurs primarily during weeks 4–16 of build-up, shows a pattern of being worst on or around injection days, and generally follows the expected timeline of resolving as maintenance dose is reached (months 3–6). Treatment failure: symptoms don't improve at all during maintenance phase despite 12+ months of consistent treatment at therapeutic dose, symptom scores don't decrease compared to pre-treatment baseline, and no reduction in medication use occurs. Track your symptoms prospectively using a validated score (TNSS) before starting and every 3 months during treatment. If you see no objective improvement by 12 months at maintenance dose, your allergist should re-evaluate extract formulation, dosing, or underlying diagnosis.
Related Articles
How Long Do Allergy Shots Take? Trial vs Reality | Curex
How long do allergy shots take to work? Trials show 12-month benefit, but only 23% complete 3 years. Real-world vs clinical data guide.
Read moreDo Allergy Shots Weaken Your Immune System? The Real Facts
Allergy shots do NOT weaken your immune system. SCIT retrains — not suppresses — immunity, unlike corticosteroids which actually do suppress it.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Shots and Eczema: Worsening Risk Explained Curex
Eczema worsening during allergy shot build-up is a real Th2 paradox in atopic patients. Learn the mechanism, expected timeline, and when to push through.
Read moreWhat Is Allergy Shots? Quick Definition and How It Works
What is allergy shots? SCIT retrains the immune system over 3–5 years and is the only disease-modifying allergy treatment; many patients get long-term relief that can persist after treatment.
Read moreCan Allergy Shots Make Existing Allergies Worse? | Curex
Allergy shot build-up worsening is expected and transient. Learn the immune mechanism, normal worsening timeline, and when it signals treatment failure.
Read moreGet your allergy shots — without the clinic.
Curex at-home shots require a program quote. Confirm what is included in your plan — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
Program quote required · Remaining payments for shipped treatment are collected on cancellation
Curex allergy shot serum is compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.